A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer (NIVEC)
- Yong Jae Lee
- , Yoo Young Lee
- , Jeong Yeol Park
- , Hyun Woong Cho
- , Myong Cheol Lim
- , Mi Kyung Kim
- , Jong Min Lee
- , Jung Yun Lee
Research output: Contribution to journal › Article › peer-review
3
Scopus
citations